JPH035475A - Optically active compound and its production - Google Patents
Optically active compound and its productionInfo
- Publication number
- JPH035475A JPH035475A JP1140798A JP14079889A JPH035475A JP H035475 A JPH035475 A JP H035475A JP 1140798 A JP1140798 A JP 1140798A JP 14079889 A JP14079889 A JP 14079889A JP H035475 A JPH035475 A JP H035475A
- Authority
- JP
- Japan
- Prior art keywords
- group
- general formula
- optically active
- alkyl group
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 49
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 10
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 26
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 19
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 15
- 125000002252 acyl group Chemical group 0.000 claims abstract description 8
- 125000003118 aryl group Chemical group 0.000 claims abstract description 7
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 7
- 125000005842 heteroatom Chemical group 0.000 claims abstract description 7
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims abstract description 6
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 6
- 239000003377 acid catalyst Substances 0.000 claims abstract description 5
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 4
- 238000010438 heat treatment Methods 0.000 claims abstract description 4
- 125000006239 protecting group Chemical group 0.000 claims abstract description 3
- 238000006243 chemical reaction Methods 0.000 claims description 22
- 239000000126 substance Substances 0.000 claims description 15
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- 230000003287 optical effect Effects 0.000 claims description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 claims description 5
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 claims description 5
- 230000015572 biosynthetic process Effects 0.000 abstract description 14
- 238000003786 synthesis reaction Methods 0.000 abstract description 14
- 150000003180 prostaglandins Chemical class 0.000 abstract description 10
- 125000000457 gamma-lactone group Chemical group 0.000 abstract description 6
- 239000002994 raw material Substances 0.000 abstract description 4
- 239000007858 starting material Substances 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract 1
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
- -1 inbutyl Chemical group 0.000 description 44
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 40
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 39
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 20
- 239000002904 solvent Substances 0.000 description 18
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
- 239000000203 mixture Substances 0.000 description 13
- QWOJMRHUQHTCJG-UHFFFAOYSA-N CC([CH2-])=O Chemical compound CC([CH2-])=O QWOJMRHUQHTCJG-UHFFFAOYSA-N 0.000 description 12
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 10
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 10
- QFXZANXYUCUTQH-UHFFFAOYSA-N ethynol Chemical class OC#C QFXZANXYUCUTQH-UHFFFAOYSA-N 0.000 description 10
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 8
- 239000000543 intermediate Substances 0.000 description 8
- 238000010898 silica gel chromatography Methods 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 7
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical group O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 7
- 150000002009 diols Chemical class 0.000 description 7
- HQQULPUXSRHOGE-UHFFFAOYSA-N 1,4-Pentadiyn-3-one Chemical class C#CC(=O)C#C HQQULPUXSRHOGE-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 229910052783 alkali metal Inorganic materials 0.000 description 6
- 150000001340 alkali metals Chemical class 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 5
- 150000002366 halogen compounds Chemical class 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 229920006395 saturated elastomer Polymers 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- PPTSRTIIAOKIOL-AWEZNQCLSA-N (2s)-2-phenylmethoxyheptanal Chemical compound CCCCC[C@@H](C=O)OCC1=CC=CC=C1 PPTSRTIIAOKIOL-AWEZNQCLSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 239000002841 Lewis acid Substances 0.000 description 4
- 150000001299 aldehydes Chemical class 0.000 description 4
- 150000004808 allyl alcohols Chemical class 0.000 description 4
- 125000005843 halogen group Chemical group 0.000 description 4
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 4
- 150000007517 lewis acids Chemical class 0.000 description 4
- 235000010355 mannitol Nutrition 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- GIZSHQYTTBQKOQ-UHFFFAOYSA-N threo-Syringoylglycerol Chemical compound COC1=CC(C(O)C(O)CO)=CC(OC)=C1O GIZSHQYTTBQKOQ-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 101150041968 CDC13 gene Proteins 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 239000012280 lithium aluminium hydride Substances 0.000 description 3
- 230000001766 physiological effect Effects 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000001308 synthesis method Methods 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- NDQXKKFRNOPRDW-UHFFFAOYSA-N 1,1,1-triethoxyethane Chemical compound CCOC(C)(OCC)OCC NDQXKKFRNOPRDW-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229910052792 caesium Inorganic materials 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 229940125898 compound 5 Drugs 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 238000000967 suction filtration Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- HDPNBNXLBDFELL-UHFFFAOYSA-N 1,1,1-trimethoxyethane Chemical compound COC(C)(OC)OC HDPNBNXLBDFELL-UHFFFAOYSA-N 0.000 description 1
- UEVZIKFSVBYKAC-UHFFFAOYSA-N 1-(1,1-dibutoxyethoxy)butane Chemical compound CCCCOC(C)(OCCCC)OCCCC UEVZIKFSVBYKAC-UHFFFAOYSA-N 0.000 description 1
- DWLUIFLANBQDBR-UHFFFAOYSA-N 1-(1,1-diheptoxyethoxy)heptane Chemical compound C(C)(OCCCCCCC)(OCCCCCCC)OCCCCCCC DWLUIFLANBQDBR-UHFFFAOYSA-N 0.000 description 1
- JDQNNHFSSCEQPM-UHFFFAOYSA-N 1-(1,1-dipropoxyethoxy)propane Chemical compound CCCOC(C)(OCCC)OCCC JDQNNHFSSCEQPM-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- MEKOFIRRDATTAG-UHFFFAOYSA-N 2,2,5,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical compound C1CC(C)(C)OC2=C1C(C)=C(O)C=C2C MEKOFIRRDATTAG-UHFFFAOYSA-N 0.000 description 1
- 125000003562 2,2-dimethylpentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 238000006568 Claisen-Johnson rearrangement reaction Methods 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- CTKINSOISVBQLD-UHFFFAOYSA-N Glycidol Chemical compound OCC1CO1 CTKINSOISVBQLD-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 1
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- ARNWQMJQALNBBV-UHFFFAOYSA-N lithium carbide Chemical compound [Li+].[Li+].[C-]#[C-] ARNWQMJQALNBBV-UHFFFAOYSA-N 0.000 description 1
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- LWLPYZUDBNFNAH-UHFFFAOYSA-M magnesium;butane;bromide Chemical compound [Mg+2].[Br-].CCC[CH2-] LWLPYZUDBNFNAH-UHFFFAOYSA-M 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- AUHZEENZYGFFBQ-UHFFFAOYSA-N mesitylene Substances CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 description 1
- 125000001827 mesitylenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- DOHXSUFORRJRAO-UHFFFAOYSA-N methanesulfonyl chloride;pyridine Chemical compound CS(Cl)(=O)=O.C1=CC=NC=C1 DOHXSUFORRJRAO-UHFFFAOYSA-N 0.000 description 1
- DVSDBMFJEQPWNO-UHFFFAOYSA-N methyllithium Chemical compound C[Li] DVSDBMFJEQPWNO-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Furan Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は、G、 5torkらによって開発されたプロ
スタグランジン合成法(G、5tork、 T、Ta
kahashi。Detailed Description of the Invention (Field of Industrial Application) The present invention is based on a prostaglandin synthesis method (G, 5tork, T, Ta
kahashi.
1、Kavvamoto、 T、5uzuki : J
、Am、Chem、Soc、、 100 。1, Kavvamoto, T, 5uzuki: J
, Am, Chem, Soc,, 100.
8272 (1978) )における重要な中間体であ
る、下記一般式(P)
R2
(上記一般式(P)において、R1はアルコキシ基を有
していてもよいアルキル基、シクロアルキル基及び芳香
環もしくはアルキル基にヘテロ原子を有するアラルキル
基から選ばれた炭素数1〜12の基、R2は水素原子又
はアシル基、シリル基、アラルキル基及びアルキルオキ
シアルキル基から選ばれた容易に脱離可能な保護基を表
わし、*の符号は不斉炭素原子を表わす)で表わされる
光学活性γ−ラクトン誘導体を製造するための中間体で
ある光学活性化合物及びその製法に関する。8272 (1978)), the following general formula (P) R2 (In the above general formula (P), R1 is an alkyl group, a cycloalkyl group, an aromatic ring, or A group having 1 to 12 carbon atoms selected from aralkyl groups having a heteroatom in the alkyl group, R2 is a hydrogen atom or an easily removable protected group selected from acyl groups, silyl groups, aralkyl groups, and alkyloxyalkyl groups. The present invention relates to an optically active compound which is an intermediate for producing an optically active γ-lactone derivative represented by a group (wherein the symbol * represents an asymmetric carbon atom), and a method for producing the same.
(従来の技術及び解決すべき課題)
プロスタグランジンの製造に関しては、上記G、 5t
orkらの合成法の伯に、コーリーラクトンや4−ヒド
ロキシシクロベンテノンより出発する方法が実用化され
ているが、この方法は原料の光学活性体を得るために光
学分割や微生物による不斉水解などの工程を経る必要が
おり、さらにこれらを基にしてα、ω側鎖を導入してい
く段階での立体制御においても問題点が多い。このよう
な点からみると上記G、 5torkらにより開発され
た前記一般式(P)の光学活性γ−ラクトン誘導体を鍵
中間体とするプロスタグランジン合成法は優れた方法で
あるといえる。しかしながら、この方法における問題点
は鍵中間体となる一般式(P)の化合物をいかに経済的
に製造できるかにかかつていた。(Prior art and problems to be solved) Regarding the production of prostaglandin, the above G, 5t
In addition to the synthetic method of Ork et al., a method starting from Corey lactone or 4-hydroxycyclobentenone has been put into practical use, but this method requires optical resolution or asymmetric hydrolysis by microorganisms to obtain optically active raw materials. It is necessary to go through the following steps, and there are also many problems in the stereoscopic control at the stage of introducing α and ω side chains based on these steps. From this point of view, the prostaglandin synthesis method using the optically active γ-lactone derivative of general formula (P) as a key intermediate, developed by G. 5tork et al., can be said to be an excellent method. However, the problem with this method lies in how economically the compound of general formula (P), which serves as a key intermediate, can be produced.
(課題を解決するための手段)
本発明者らは、上記問題点を解決すべく鋭意検討の結果
、鍵中間体でおる上記一般式(P)で表わされる化合物
を従来より簡便に、且つ効率よく製造する方法を見出し
たものであり、本発明はこの製造の過程で得られる中間
体及びその製法を提供するものでおる。(Means for Solving the Problems) As a result of intensive studies to solve the above problems, the present inventors have discovered that the compound represented by the above general formula (P), which is a key intermediate, can be produced more easily and efficiently than before. The present invention provides an intermediate obtained in the process of this production and a method for producing the same.
本発明は、下記一般式(△)
(上記一般式(A>において、R1はアルコキシ基を有
していてもよいアルキル基、シクロアルキル基及び芳香
環もしくはアルキル基にヘテロ原子を有するアラルキル
基から選ばれた炭素数1〜12の基、R2は水素原子又
はアシル基、シリル基、アラルキル基及びアルキルオキ
シアルキル基から選ばれた容易に脱離可能な保護基、R
4は炭素数1〜5の低級アルキル基を表わし、*の符号
は不斉炭素原子を表わす)
で表わされる光学活性化合物及びその製法でおる。The present invention is based on the following general formula (△) (in the above general formula (A>), R1 is an aralkyl group having a hetero atom in an aromatic ring or alkyl group, an alkyl group that may have an alkoxy group, a cycloalkyl group, and an aromatic ring or an aralkyl group having a heteroatom in the alkyl group. A selected group having 1 to 12 carbon atoms, R2 is a hydrogen atom or an easily removable protecting group selected from an acyl group, a silyl group, an aralkyl group, and an alkyloxyalkyl group, R
4 represents a lower alkyl group having 1 to 5 carbon atoms, and the symbol * represents an asymmetric carbon atom) and a method for producing the same.
上記一般式(A)におけるR1の具体例とじては、メチ
ル、エチル210ビル、イソプロピル。Specific examples of R1 in the above general formula (A) include methyl, ethyl 210 biru, and isopropyl.
ブチル、インブチル、ペンチル、イソペンチル22.2
−ジメチルペンチル、ヘキシル、2−ヘキシル、ヘプヂ
ル、2−ヘプチル、オクチル、2−オクチル、ノニル、
2−ノニル、デシル、2−デシル、ウンデシル、2−ウ
ンデシル、ドデシル。Butyl, inbutyl, pentyl, isopentyl 22.2
-dimethylpentyl, hexyl, 2-hexyl, hepdyl, 2-heptyl, octyl, 2-octyl, nonyl,
2-nonyl, decyl, 2-decyl, undecyl, 2-undecyl, dodecyl.
2−エトキシ−1,1−ジメチルエチル、5−メトキシ
−1−メチルペンチル、シクロペンチル。2-ethoxy-1,1-dimethylethyl, 5-methoxy-1-methylpentyl, cyclopentyl.
3−エチルシクロペンチル、シクロヘキシル。3-Ethylcyclopentyl, cyclohexyl.
2−メチルシクロヘキシル、4−n−プロピルシクロヘ
キシルなどのアルコキシ置換基を有していてもよい直鎖
状もしくは分岐状アルキル基又はシクロアルキル基、フ
ェニルオキシメチル、3−トリフルオロメチルフェニル
オキシメチル、2−クロロチオフェン−5−イルオキシ
メチル、フラン−2−イル−2−エチルなどの芳香環も
しくはアルキル基にヘテロ原子を有するアラルキル基が
挙げられる。Straight chain or branched alkyl group or cycloalkyl group optionally having an alkoxy substituent such as 2-methylcyclohexyl, 4-n-propylcyclohexyl, phenyloxymethyl, 3-trifluoromethylphenyloxymethyl, 2 -Chlorothiophen-5-yloxymethyl, furan-2-yl-2-ethyl, and other aralkyl groups having a heteroatom in an aromatic ring or an alkyl group can be mentioned.
上記一般式(A>における水素原子以外のR2の具体例
としては、ベンゾイル、アセチル、p−フェニルベンゾ
イルなどのアシル基、t−ブチルメチルシリル、トリメ
チルシリル、 ℃−ブチルジフェニルシリルなどのシリ
ル基、ベンジル、4−二トロフェニルメチルなどのアラ
ルキル基、テトラヒドロピラニル、 1−エトキシエチ
ルなどのアルキルオキシアルキル基等の容易に脱離可能
な基が挙げられる。Specific examples of R2 other than hydrogen atoms in the above general formula (A>) include acyl groups such as benzoyl, acetyl, and p-phenylbenzoyl; silyl groups such as t-butylmethylsilyl, trimethylsilyl, and °C-butyldiphenylsilyl; benzyl; , aralkyl groups such as 4-nitrophenylmethyl, tetrahydropyranyl, alkyloxyalkyl groups such as 1-ethoxyethyl, and easily removable groups.
上記一般式(A>におけるR4の具体例としては、メチ
ル、エチル、プロピル、ブチル、ペンチルなどの基が挙
げられる。Specific examples of R4 in the above general formula (A>) include groups such as methyl, ethyl, propyl, butyl, and pentyl.
プロスタグランジンは生体内でプロスタグランジン合成
酵素によりアラキドン酸などの高級不飽和脂肪酸が化学
変換されて生じる極めて強い生理活性をもつ化合物で下
記のような構造を有している。Prostaglandins are compounds with extremely strong physiological activity that are produced by chemical conversion of higher unsaturated fatty acids such as arachidonic acid by prostaglandin synthase in vivo, and have the following structure.
OH
OH
GF
OH
GE
天然のプロスタグランジンでは、R1はn −05H1
1−1Rは(CH2) 6COOH又はCH2CH=C
H(CH2)3 C0OHでめり、R1の置換基は脂溶
性を有することが生理活性の発現上重要であることが知
られている。医薬品としての開発研究が進められる中で
ざらにR1としてアルキル基、シクロアルキル基又はア
ラルキル基でおって炭素数4〜10のものが有効であり
、例えばペンチル、イソペンチル、2,2−ジメチルペ
ンチル、ヘキシル、2−ヘキシル、ヘプチル、2−エト
キシ−1,1−ジメチルエチル、5−メトキシ−1−メ
チルペンチルなどのアルキル基、シクロペンチル、3−
エチルシクロペンチル、4−プロピルシクロヘキシルな
どのシクロアルキル基、フェニルオキシメチル、3−ト
リフルオロメチルフェニルオキシメチル、2−クロロチ
オフェン−5−イルオキシメチル、フラン−2−イル−
2−エチルなどのアラルキル基などが特に強い生理活性
を示すことが明らかにされてきた。本発明の化合物はこ
れら有機基を含めた置換基を導入することのできる原料
として有用なものでおる。OH OH GF OH GE In natural prostaglandins, R1 is n -05H1
1-1R is (CH2) 6COOH or CH2CH=C
It is known that it is important for the expression of physiological activity that the substituent group R1 has lipid solubility. As R1 is being developed and researched as a pharmaceutical, an alkyl group, cycloalkyl group, or aralkyl group with 4 to 10 carbon atoms is generally effective, such as pentyl, isopentyl, 2,2-dimethylpentyl, Alkyl groups such as hexyl, 2-hexyl, heptyl, 2-ethoxy-1,1-dimethylethyl, 5-methoxy-1-methylpentyl, cyclopentyl, 3-
Cycloalkyl groups such as ethylcyclopentyl, 4-propylcyclohexyl, phenyloxymethyl, 3-trifluoromethylphenyloxymethyl, 2-chlorothiophen-5-yloxymethyl, furan-2-yl-
It has been revealed that aralkyl groups such as 2-ethyl exhibit particularly strong physiological activity. The compounds of the present invention are useful as raw materials into which substituents including these organic groups can be introduced.
本発明の上記一般式(A>で表わされるγ−不飽和カル
ボン酸誘導体の合成法を以下合成経路工に従って説明す
る。下記において、Xはハロゲン原子、Mはアルカリ金
属を表わす。The method for synthesizing the γ-unsaturated carboxylic acid derivative represented by the general formula (A>) of the present invention will be explained below according to the synthetic route. In the following, X represents a halogen atom and M represents an alkali metal.
(1)
(2′
)
(4)
く2)
(5)
(6)
(B)
(A>
上記反応において、ハロゲン化合物(1)にn−ブチル
リチウム、t−ブチルリチウム、メチルリチウム、リチ
ウムジイソプロピルアミドなどの強塩基を作用させてア
セチレン化合物(2)とし、ざらにこれらの強塩基によ
りアルカリ金属アセチリド(2′)とする。これに光学
活性アルデヒド(3)を作用させると化合物(4)が得
られる。(1) (2') (4) Ku2) (5) (6) (B) (A> In the above reaction, n-butyllithium, t-butyllithium, methyllithium, lithium diisopropyl is added to the halogen compound (1). Acetylene compound (2) is produced by reacting with a strong base such as amide, and then alkali metal acetylide (2') is produced by using these strong bases. Compound (4) is produced by reacting optically active aldehyde (3) with this. can get.
上記アルカリ金属アセチリド(2′)は、上記のように
アセチレン化合物(2)を−度単離して再度強塩基と反
応させて調製してもよいが、より簡便にはハロゲン化合
物(1)を2倍量以上の強塩基と反応させて得られるア
ルカリ金属アセチリドをそのまま用いることができる。The alkali metal acetylide (2') may be prepared by isolating the acetylene compound (2) as described above and reacting it again with a strong base, but more simply, the halogen compound (1) is Alkali metal acetylides obtained by reacting with twice or more of a strong base can be used as they are.
このアルカリ金属アセチリドと光学活性アルデヒド(3
)との反応は一78〜O℃の低温で行うことが望ましい
。This alkali metal acetylide and optically active aldehyde (3
) is preferably carried out at a low temperature of -78°C to 0°C.
化合物(4)を得る反応はテトラヒドロフラン。The reaction to obtain compound (4) is tetrahydrofuran.
ジイソプロピルエーテル、トルエンなどの不活性溶媒中
−78℃〜室温の温度範囲で行うことができる。この反
応によって得られる化合物(4)は下記化学式で示され
るようにエリトロ体(6−1)とトレオ体(6−2)の
混合物でおる。It can be carried out in an inert solvent such as diisopropyl ether or toluene at a temperature range of -78°C to room temperature. Compound (4) obtained by this reaction is a mixture of erythro form (6-1) and threo form (6-2) as shown by the following chemical formula.
(6−1ン
H
この混合物からエリトロ体(6−1>又はトレオ体(6
−2>を選択的に得るにはカラム分離などによって分割
することができるが、1麦述するような化学的方法によ
って簡便に、しかもより選択的にそれぞれの光学異性体
を製造することができる。この化合物(4)に酸化剤、
例えばCr03−ピリジン、ジメチルスルホキシド(D
MSO)−酸ハライドなどを用いて酸化することにより
化合物く5)のエチニルケトン誘導体を得ることができ
る。(6-1-H) From this mixture, erythro form (6-1> or threo form (6-1)
-2> can be separated by column separation etc., but each optical isomer can be easily and more selectively produced by the chemical method described in 1. . This compound (4) has an oxidizing agent,
For example, Cr03-pyridine, dimethyl sulfoxide (D
The ethynyl ketone derivative of compound 5) can be obtained by oxidation using MSO)-acid halide or the like.
この化合物(5)より光学活性エチニルアルコール誘導
体(6)を合成する反応は、iqようとするエチニルア
ルコール誘導体(6)が前記化学式で示したエリトロ体
(6−1>でおるか、またはトレオ体(6−2>である
かによって反応条件が異なる。即ち、エリトロ体(6−
1>を目的とする場合は化合物く5)を水素化ホウ素亜
鉛錯体(Zn (BHa ) 2 )で、またトレオ体
(6−2>を目的とする場合はアルカリ金属セレクトリ
ド、例えばカリウムセレクトリドで還元することにより
良好な選択性をもって目的とする立体配置のエチニルア
ルコール誘導体く6)を得ることができる。The reaction for synthesizing the optically active ethynyl alcohol derivative (6) from the compound (5) is carried out in such a way that the ethynyl alcohol derivative (6) to be iq is either the erythro form (6-1>) shown in the above chemical formula or the threo form. The reaction conditions differ depending on whether (6-2>).In other words, the erythro form (6-2>
1>, the compound 5) is a borohydride zinc complex (Zn (BHa) 2), and when the purpose is the threo form (6-2>, an alkali metal selectride, such as potassium selectride) is used. By reducing with , the ethynyl alcohol derivative 6) having the desired configuration can be obtained with good selectivity.
上記エチニルアルコール誘導体(6)は、続いて水素化
リチウムアルミニウム等で三重結合をトランス二重結合
へ還元してアリルアルコール誘導体(B)へ導かれる。The above ethynyl alcohol derivative (6) is then led to the allyl alcohol derivative (B) by reducing the triple bond to a trans double bond with lithium aluminum hydride or the like.
この反応はテトラヒドロフラン、ジオキサン等の不活性
溶媒中40〜80℃の温度で行うことができる。This reaction can be carried out in an inert solvent such as tetrahydrofuran or dioxane at a temperature of 40 to 80°C.
アリルアルコール誘導体(B)は、下記一般式(
%式%()
(上記一般式(D>において、R4は炭素数1〜5の低
級アルキル基を表わす)
で表わされるオルト酢酸トリアルキルと共に酸触媒の存
在下で加熱反応させ、ジョンソン−クライゼン転位反応
を行うことにより本発明の目的物であるγ−不飽和カル
ボン酸誘導体(A>を得ることができる。上記一般式(
D)のオルト酢酸トリアルキルとしてはオルト酢酸トリ
メチル、オルト酢酸トリエチル、オルト酢酸トリプロピ
ル、オルト酢酸トリブチル、オルト酢酸トリヘプチル等
が挙げられ、これをアリルアルコール誘導体(B)に対
して2〜10倍当量用い、トルエン、キシレン。The allyl alcohol derivative (B) is an acid catalyst together with trialkyl orthoacetate represented by the following general formula (% formula % () (in the above general formula (D>), R4 represents a lower alkyl group having 1 to 5 carbon atoms). The γ-unsaturated carboxylic acid derivative (A>) which is the object of the present invention can be obtained by carrying out a heating reaction in the presence of and carrying out a Johnson-Claisen rearrangement reaction.The above general formula (
Examples of the trialkyl orthoacetate in D) include trimethyl orthoacetate, triethyl orthoacetate, tripropyl orthoacetate, tributyl orthoacetate, triheptyl orthoacetate, etc., in an amount of 2 to 10 times equivalent to the allyl alcohol derivative (B). used, toluene, xylene.
メシチレン等の溶媒中130〜180’Cの温度で反応
が行われる。酸触媒としてはルイス酸、ルイス酸錯体(
例えばBF3・(C2R5) 20)やヘプタン酸など
の有機酸が用いられる。The reaction is carried out in a solvent such as mesitylene at a temperature of 130-180'C. Lewis acids and Lewis acid complexes (
For example, organic acids such as BF3.(C2R5) 20) and heptanoic acid are used.
上記反応における出発物質であるハロゲン化合物(1)
は、D−マンニトールや光学活性グリシドールから公知
の方法で得られる光学活性2,3−0−イソプロピリデ
ングリセルアルデヒドをトリフェニルホスフィン及びテ
トラハロメタンと反応させることにより容易に合成でき
る。Halogen compound (1) as a starting material in the above reaction
can be easily synthesized by reacting optically active 2,3-0-isopropylidene glyceraldehyde obtained from D-mannitol or optically active glycidol by a known method with triphenylphosphine and tetrahalomethane.
また、上記光学活性アルデヒド(3)は、下記合成経路
■に従って合成することができる。下記において、R1
,R2及び*の符号は一般式(A>のR1,R2及び*
の符号と同様の意味を表わし、X、Yは、それぞれ独立
して水酸基、アシル基。Further, the above-mentioned optically active aldehyde (3) can be synthesized according to the following synthetic route (2). In the following, R1
, R2 and * are the general formula (R1, R2 and * of A>
, and X and Y each independently represent a hydroxyl group or an acyl group.
スルホキシ基及びハロゲン原子から選ばれた基又(C)
Ca”)
(d>
(f)
(3)
上記光学活性マンニトールをアセトンと酸触媒の存在下
で反応させてトリアセトニド(a)とし、これを含水酢
酸で部分加水分解してテトラオール(b)とし、これの
−級水酸基及び二級水酸基を各々別個にトリフェニルホ
スフィン−CCJla、酸ハライド−ピリジン、ピリジ
ン−メタンスルホニルクロリドなどで選択的にアシル基
、スルホキシ基又はハロゲン原子で一部又は全部を変換
してアセトニド(C)とする。次いでこのアセトニド(
C)を塩基でジエポキシド(d)とした後、R3MgB
r、R3MgBr−CCl2 (CN)2゜R3Li
(但し、R3はR1より炭素数が1個少ない基を表わす
)や水素化リチウムアルミニウムなどでR1基を導入し
、ざらに水酸基をR2X’(X’ はハロゲン原子又は
スルホキシ基)と反応させてアセトニド(e)とし、こ
れを加水分解しrシフJ −/l、 (f )とした後
、Pb (OAc)aやNa104などで酸化して目的
の光学活性アルデヒド(3)を得ることができる。A group selected from a sulfoxy group and a halogen atom or (C) Ca") (d> (f) (3) The above optically active mannitol is reacted with acetone in the presence of an acid catalyst to form triacetonide (a), and this is Tetraol (b) is partially hydrolyzed with aqueous acetic acid, and its -class and secondary hydroxyl groups are selectively converted into acyl with triphenylphosphine-CCJla, acid halide-pyridine, pyridine-methanesulfonyl chloride, etc. group, sulfoxy group or halogen atom to give acetonide (C).Then, this acetonide (C) is converted into acetonide (C).
After converting C) to diepoxide (d) with a base, R3MgB
r, R3MgBr-CCl2 (CN)2゜R3Li
(However, R3 represents a group with one less carbon number than R1) or lithium aluminum hydride to introduce the R1 group, and roughly react the hydroxyl group with R2X'(X' is a halogen atom or a sulfoxy group). After acetonide (e) is hydrolyzed to give rSchiff J −/l, (f), it can be oxidized with Pb(OAc)a, Na104, etc. to obtain the desired optically active aldehyde (3). .
上記得られた本発明の目的物である一般式<A)で表わ
される光学活性T−不飽和カルボン酸誘導体は、下記合
成式で示すようにプロスタグランジン合成における鍵中
間体である化合物(P)のT−ラクトン誘導体に変換す
ることができる。The optically active T-unsaturated carboxylic acid derivative represented by the general formula <A), which is the object of the present invention obtained above, is a compound (P ) can be converted into T-lactone derivatives.
(A)
0
R2
(P)
上記反応において、γ−不飽和カルボン酸誘導体(A)
は、このもののアセトニドを酸触媒で開環させ、分子内
ラクトン化させると光学活性r−ラクトン誘導体(P)
が得られる。この反応におけるアセトニドの加水分解は
含水有機酸、メタノール、エタノール等のアルコール、
アセトン又はジオキサンなどの溶媒中鉱酸やBF3 ・
エーテル錯体、CLISO4,Zn5Oa等のルイス酸
又はルイス酸錯体を用いて空温〜80°Cの温度で行う
ことができる。(A) 0 R2 (P) In the above reaction, γ-unsaturated carboxylic acid derivative (A)
When the acetonide of this product is ring-opened with an acid catalyst and intramolecularly lactonized, it becomes an optically active r-lactone derivative (P).
is obtained. Hydrolysis of acetonide in this reaction can be carried out using hydrous organic acids, alcohols such as methanol and ethanol,
Mineral acid or BF3 in a solvent such as acetone or dioxane.
It can be carried out using an ether complex, a Lewis acid such as CLISO4, Zn5Oa, or a Lewis acid complex at a temperature of air temperature to 80°C.
このようにして得られた一般式(P)の化合物は、前記
G、 5torkらのプロスタグランジン合成法に従っ
てプロスタグランジン(前記PGE、PGF)に導くこ
とができる。従って本発明における一般式(A>の光学
活性化合物は、上記原料としては一般式(A)中の1°
位、3位及び6位の立体配置はいづれもSであることが
必要とされる。The compound of general formula (P) thus obtained can be converted into prostaglandin (the above-mentioned PGE, PGF) according to the above-mentioned prostaglandin synthesis method of G. 5tork et al. Therefore, in the present invention, the optically active compound of general formula (A>
The steric configurations at the 3rd, 3rd and 6th positions are all required to be S.
以下実施例によって本発明を説明する。The present invention will be explained below with reference to Examples.
(実 施 例)
実施例
〈化合物(a)の合成〉
45(lのD−マンニトールをアセトン1g及び濃塩酸
1d中で空温下3日間激しく撹拌した後、炭酸カリウム
50(lを加え、ざらに1日撹拌した。固形物を吸引濾
過して除き、濾液中の溶媒を減圧下に留去し、得られた
残渣に水を加え、析出した結晶を吸引濾取して粗生成物
45gを得た。これをエタノール20rn1に加熱溶解
した後濾過し、濾液を空温に冷却して析出した結晶を濾
取し、下記化学式で示される光学活性(2R,3R,4
R,5R)体のトリアセトニド(a) 37.3q(
収率50%)を得た。(Example) Example <Synthesis of compound (a)> After 45 (l) of D-mannitol was stirred vigorously in 1 g of acetone and 1 d of concentrated hydrochloric acid under air temperature for 3 days, 50 (l) of potassium carbonate was added and The solid matter was removed by suction filtration, the solvent in the filtrate was distilled off under reduced pressure, water was added to the resulting residue, and the precipitated crystals were collected by suction filtration to obtain 45 g of a crude product. This was heated and dissolved in 20rn1 of ethanol and then filtered, the filtrate was cooled to air temperature, the precipitated crystals were collected by filtration, and the optical activity (2R, 3R, 4
R,5R) triacetonide (a) 37.3q(
A yield of 50% was obtained.
(0,72(II>を濾別し、濾液よりアセトンを減圧
留去してシロップ状の生成物を得た。これをベンゼン5
0dで再結晶して下記化学式で示される光学活性(2R
,3R,4R,5R)体のテトラオール(b)8.8g
(収率80%)を得た。(0,72(II>) was filtered off, and acetone was distilled off from the filtrate under reduced pressure to obtain a syrup-like product.
After recrystallization at 0d, the optical activity (2R
, 3R, 4R, 5R) tetraol (b) 8.8 g
(yield 80%).
’HNMR(CCIla )
δ:1.40 (6H,S、CH3X2 )1.
43 (12H,S、 CH3X4 )3.7〜
4.4 (8H,m、CH2、CH)く化合物(b)
の合成〉
上記得られたトリアセトニド(a) 15(J(0,
05mol)を70%酢!50m1中40’Cで3.5
時間撹拌した後、40℃で出来更迭やかに減圧濃縮し、
残渣にアセトンを加え結晶化したD−マンニトール’H
NMR(D20)
δ :1.38 (6H,S、 CH
3X2 )3.3〜4.2 (8H,m、CH2、
CH)〈化合物(C)及び(d>の合成〉
上記得られたテトラオール(b) 15.3g(0,
069mol ) 、無水ピリジン55d (0,68
mol >、CH2CJ1250mlの溶液中に、−7
0°Cで塩化ベンゾイル16d (0,138mol
) 、無水CH2Ce25mの混合液を15分間かけて
滴下し、滴下後更に一30’Cで1時間、空温で10時
間撹拌し、反応の完結を薄層クロマトグラフで確認した
後溶媒を減圧留去した。'HNMR (CCIla) δ: 1.40 (6H,S,CH3X2)1.
43 (12H,S, CH3X4) 3.7~
4.4 (8H,m,CH2,CH) compound (b)
Synthesis of triacetonide (a) 15(J(0,
05mol) to 70% vinegar! 3.5 at 40'C in 50m1
After stirring for an hour, it was quickly concentrated under reduced pressure at 40°C.
D-mannitol'H crystallized by adding acetone to the residue
NMR (D20) δ: 1.38 (6H,S, CH
3X2) 3.3~4.2 (8H, m, CH2,
CH) <Synthesis of compounds (C) and (d>> Tetraol (b) obtained above 15.3 g (0,
069 mol), anhydrous pyridine 55d (0,68
mol >, -7 in a solution of 1250 ml of CH2CJ
Benzoyl chloride 16d (0,138 mol
), a mixed solution of 25 m of anhydrous CH2Ce was added dropwise over 15 minutes, and after the dropwise addition, the mixture was further stirred at -30'C for 1 hour and at air temperature for 10 hours. After confirming the completion of the reaction with thin layer chromatography, the solvent was distilled off under reduced pressure. I left.
この残渣にメタンスルホニルクロリド11.2d(0,
144mol >をO’Cで20分間かけて加え、更に
この懸濁液を室温で3日間撹拌した。反応の完結を薄層
クロマトグラフで確認した後、反応混合物にエチルエー
テル:ヘキサン=7:3(容量)の混合溶媒100mZ
を加え、この黄色の懸濁液をセライト−545で濾過し
、溶媒を減圧留去した。得られた褐色の残渣をCH2C
l2で希釈し、濃塩酸を加えて酸性にしだ後CH2Cf
12で3回抽出した。抽出物を飽和重曹水、飽和食塩水
で順次洗浄した後無水硫酸マグネシウムで乾燥し、溶媒
を減圧留去して下記化学式で示される光学活性(2R,
3R,4R。To this residue was added 11.2 d of methanesulfonyl chloride (0,
144 mol> was added over 20 minutes at O'C and the suspension was further stirred at room temperature for 3 days. After confirming the completion of the reaction by thin layer chromatography, 100 mZ of a mixed solvent of ethyl ether:hexane = 7:3 (volume) was added to the reaction mixture.
was added, and the yellow suspension was filtered through Celite-545, and the solvent was distilled off under reduced pressure. The resulting brown residue was dissolved in CH2C.
After diluting with l2 and making it acidic by adding concentrated hydrochloric acid, CH2Cf
12 and extracted three times. The extract was washed successively with saturated sodium bicarbonate solution and saturated brine, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain the optically active compound (2R,
3R, 4R.
5R)体の褐色半固体物アセトニド(c)42gを得た
。42 g of acetonide (c), a brown semi-solid substance of the 5R) form, was obtained.
(C)
(但し、MSはメチルスルホキシ基、phは)工二ル基
を表わす)
上記アセトニド(C) 42L K2 CO320C
lをメタノール130d中で15時間撹拌した後、反応
液をセライト−545を通して濾過し、濾液を40’C
で減圧濃縮し、エチルエーテル:ヘキサン=7:3(容
量)の混合溶媒30m1を加えて再度セライト−545
で濾過し、溶媒を40°Cで減圧留去し、ざらに減圧蒸
留により粗生成物を得た。これをざらにベンゼンで再結
晶して純粋な下記化学式で示される光学活性(23,3
R,4R,53)体のジエポキシド(d)2.7g(収
率21%)を得た。(C) (However, MS represents a methylsulfoxy group, and pH represents an engineering group) The above acetonide (C) 42L K2 CO320C
After stirring 15 h in 130 d of methanol, the reaction solution was filtered through Celite-545, and the filtrate was heated at 40'C.
Concentrate under reduced pressure with
The solvent was distilled off under reduced pressure at 40°C, and a crude product was obtained by distillation under reduced pressure. This is roughly recrystallized from benzene to obtain a pure optical activity (23,3
2.7 g (yield 21%) of diepoxide (d) of R, 4R, 53) form was obtained.
’HNMR(CDCb )
δ:1.39 6H,S、CH:IX2 )2.
6〜2.9 4H,m、 CH2X2 )2.95〜
3.12 2H,m、CH)3.7〜3.95 2H,
m、 CH)く化合物(e)及び f)の合成〉
Cu2 (CN)2 320mg、無水テトラヒドロ
フラン100rd!の混合物に、別途調製した濃度1.
47molの叶ブチルマグネシウムプロミドのエーテル
溶液6he (94m not )をo’cで5分間か
けて加えた。ざらに5分間撹拌した後、上記得られたジ
エポキシド(d> 6.48aの無水テトラヒドロフ
ラン50d溶液をO’Cで撹拌下10分間かけて滴下し
、ざらに1時間撹拌した。反応の完結を薄層クロマトグ
ラフで確認した後、NHa Cflと飽和食塩水で分解
し、30分間撹拌後、エチルエーテルで3回抽出し、エ
ーテル層を1規定塩酸、飽和重曹水、飽和食塩水で順次
洗浄し、無水硫酸マグネシウムで乾燥して濾過し、濾液
の溶媒を留去して下記化学式で示される光学活性(68
,7R,8R,9S)体の粗ジオール(e−1)を得た
。'HNMR(CDCb) δ:1.39 6H,S,CH:IX2)2.
6~2.9 4H, m, CH2X2)2.95~
3.12 2H, m, CH) 3.7-3.95 2H,
m, CH) Synthesis of compounds (e) and f)> Cu2 (CN)2 320 mg, anhydrous tetrahydrofuran 100rd! A separately prepared concentration 1.
A solution of 47 mol of butylmagnesium bromide in ether (94 m not ) was added over 5 minutes at o'c. After roughly stirring for 5 minutes, a solution of the diepoxide (d>6.48a) obtained above in 50 d of anhydrous tetrahydrofuran was added dropwise over 10 minutes with stirring at O'C, and the mixture was stirred roughly for 1 hour. After confirming with layer chromatography, it was decomposed with NHa Cfl and saturated brine, stirred for 30 minutes, extracted three times with ethyl ether, and the ether layer was washed successively with 1N hydrochloric acid, saturated aqueous sodium bicarbonate, and saturated brine. It was dried over anhydrous magnesium sulfate and filtered, and the solvent of the filtrate was distilled off to obtain the optical activity (68
, 7R, 8R, 9S) crude diol (e-1) was obtained.
上記得られた粗ジオール(e−1>を無水テトラヒドロ
フラン30rrdlに溶かし、これに水素化ナトリウム
0.48a (1,07m mol )の無水テトラヒ
ドロ7ラン10hj!を還流下15分間かけて滴下し、
ざらに1時間撹拌還流した後O℃に冷却した。この懸濁
液にDC−18−クラウンエーテル−6132m(lと
臭化ベンジル9.3m (78m mol>をO′Cで
加えて4時間撹拌還流した。反応液を減圧S縮し、1規
定mMで分解した後へキサンで3回抽出し、抽出液を飽
和重曹水、飽和食塩水で洗浄し、無水硫酸マグネシウム
で乾燥した後溶媒を減圧留去して下記化学式で示される
光学活性(63,7R,8R,93)体のアセトニド(
e−2>を得た。The crude diol (e-1> obtained above was dissolved in 30 rrdl of anhydrous tetrahydrofuran, and 10 hj! of anhydrous tetrahydrofuran containing 0.48a (1,07 mmol) of sodium hydride was added dropwise thereto over 15 minutes under reflux.
After roughly stirring and refluxing for 1 hour, the mixture was cooled to 0°C. To this suspension, 2 m (l) of DC-18-crown ether and 9.3 m (78 m mol) of benzyl bromide were added at O'C, and the mixture was stirred and refluxed for 4 hours. The extract was washed with saturated aqueous sodium bicarbonate and saturated brine, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain the optically active compound (63, 7R, 8R, 93) acetonide (
e-2> was obtained.
ルエーテル:ヘキサン=1:4(容量)で溶出)、下記
化学式で示される光学活性(63,7R,8R,9S)
体のジオール(f) 8.86g(化合物(d)より
の収率55%)を得た。(eluted with ether:hexane=1:4 (volume)), optical activity represented by the following chemical formula (63,7R,8R,9S)
8.86 g of diol (f) (yield 55% from compound (d)) was obtained.
(但し、3nはベンジル基を表わす)
上記アセトニド(e−2>を80%酢11007中10
0’Cで10時間加熱撹拌した後、溶媒を減圧留去し、
次いでエチルエーテルで抽出し、抽出液を苛性ソーダ水
溶液で洗浄し、水層はさらにエチルエーテルで抽出し、
これらエーテル層を併せて1規定塩酸、飽和重曹水、食
塩水で順次洗浄して無水硫酸マグネシウムで乾燥した。(However, 3n represents a benzyl group) The above acetonide (e-2>) in 80% vinegar 11007
After heating and stirring at 0'C for 10 hours, the solvent was distilled off under reduced pressure.
Next, it was extracted with ethyl ether, the extract was washed with an aqueous solution of caustic soda, and the aqueous layer was further extracted with ethyl ether.
These ether layers were combined, washed successively with 1N hydrochloric acid, saturated sodium bicarbonate solution, and brine, and dried over anhydrous magnesium sulfate.
溶媒を留去後シリカゲルカラムクロマトグラフィーで精
製しくエチ(但し、Bnはベンジル基を表わす)
1HNMR(CDC13)
δ:0.88 (8H,br、CH3X2 >1
.0〜1.8 (16H,m、 CH2X8 >3.
4〜3.7 (4H,m、CH)4.46 (
2H,d、 J=10.8112. CH)4.62
(2H,d、 J=10.8H2,CH)7.3
0 (10H,S、 Cs Hs )〈化合物(
3)の合成〉
上記得られたジオール(f) 200mg、K2 C
0360mg及び無水ベンゼン4.5d中に四節酸鉛2
60mgを4℃で加えて3分間撹拌した。反応終了後ヘ
キサン100r111を加え、セライト−545を用い
て濾過し、濾液を飽和重曹水で洗浄し、水層をヘキサン
で2回抽出し、ヘキサン層を併せて飽和食塩水で洗浄し
た後無水硫酸マグネシウムで乾燥した。溶媒を留去後、
シリカゲルカラムクロマトグラフィー(エチルエーテル
:ヘキサン=1:2 (容量〉)で精製して(S)−2
−ベンジルオキシヘプタナール(3) 160n+g
(収率80%)を得た。After evaporating the solvent, it was purified by silica gel column chromatography (however, Bn represents a benzyl group) 1HNMR (CDC13) δ: 0.88 (8H, br, CH3X2 >1
.. 0 to 1.8 (16H, m, CH2X8 >3.
4-3.7 (4H, m, CH) 4.46 (
2H, d, J=10.8112. CH) 4.62
(2H, d, J=10.8H2,CH)7.3
0 (10H,S, Cs Hs)〈Compound (
Synthesis of 3)> 200 mg of the diol (f) obtained above, K2C
0360 mg and 4.5 d of anhydrous benzene
60 mg was added at 4°C and stirred for 3 minutes. After the reaction, 100r111 of hexane was added, filtered through Celite-545, the filtrate was washed with saturated aqueous sodium bicarbonate, the aqueous layer was extracted twice with hexane, the hexane layers were combined and washed with saturated brine, and then anhydrous sulfuric acid was added. Dry with magnesium. After distilling off the solvent,
Purified by silica gel column chromatography (ethyl ether:hexane = 1:2 (volume)) to obtain (S)-2
-Benzyloxyheptanal (3) 160n+g
(yield 80%).
3.73 (1H,dt、 J= 2.2t(z
。3.73 (1H, dt, J= 2.2t(z
.
6.2H2,CH)
4.51 (IH,d、 J=11.6H2,
Cl−1>4.65 (IH,d、 J=11.
6Hz、 CH)7.34 (5H,S、 Ce
Hs )9.64 (IH,d、 J
= 2.2Hz>〈化合物(4)の合成〉
下記化学式(1)
(但し、Bnはベンジル基を表わす)
’HNMR(CDC13)
δ:0.87 (3H,t、 J= 5.8Hz
。6.2H2, CH) 4.51 (IH, d, J=11.6H2,
Cl-1>4.65 (IH, d, J=11.
6Hz, CH)7.34 (5H,S, Ce
Hs ) 9.64 (IH, d, J
= 2.2Hz><Synthesis of compound (4)> Chemical formula (1) below (however, Bn represents a benzyl group) 'HNMR (CDC13) δ: 0.87 (3H, t, J = 5.8Hz
.
CH3)
1.0〜1.8 (8H,m、 CH2)で表わされ
る(S)−ジブロマイド4.8g(16,8mmol)
の無水テトラヒドロフラン10Mを一78°Cに冷却し
、窒素雰囲気下で濃度1.62molのブチルリチウム
−ヘキサン溶液16.4d (26,6m mol )
を10分間かけて滴下し、−78°Cでざらに1時間、
空温で1時間撹拌して光学活性リチウムアセチリド(2
′)に変換し、これを−78℃に冷却して上記得られた
(S)=2−ペンジルオキシヘプタナ−ル(3) 2
.41g(4,4mmol>の無水テトラヒドロフラン
20dを滴下し、30分間更に撹拌した後、塩化アンモ
ニウム水溶液で分解し、エチルエーテルで3回抽出して
飽和食塩水で洗浄した後無水硫酸マグネシウムで乾燥し
た。溶媒を減圧留去し、シリカゲルカラムクロマトグラ
フィー(エチルエーテル:ヘキサン=1:3(容量))
で精製して下記化学式(4)で表わされる(28.6S
)体の化合物3.81gを得た(収率64%)。このも
のはエリトロ体ニドレオ体=64:36(重量)の混合
物であった。4.8 g (16.8 mmol) of (S)-dibromide represented by CH3) 1.0 to 1.8 (8H, m, CH2)
10 M of anhydrous tetrahydrofuran was cooled to -78°C, and 16.4 d (26.6 mmol) of a butyllithium-hexane solution with a concentration of 1.62 mol was added under a nitrogen atmosphere.
was added dropwise over 10 minutes, and then heated at -78°C for approximately 1 hour.
Stir at air temperature for 1 hour to obtain optically active lithium acetylide (2
') and cooled to -78°C to obtain the above-obtained (S) = 2-penzyloxyheptanal (3) 2
.. 41 g (4.4 mmol) of anhydrous tetrahydrofuran (20 d) was added dropwise, and after further stirring for 30 minutes, the mixture was decomposed with an aqueous ammonium chloride solution, extracted three times with ethyl ether, washed with saturated brine, and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure and subjected to silica gel column chromatography (ethyl ether:hexane=1:3 (volume)).
It is purified by the following chemical formula (4) (28.6S
) compound (3.81 g) was obtained (yield 64%). This product was a mixture of erythro and nidoleo forms = 64:36 (by weight).
(但し、Bnはベンジル基を表わす)
〈化合物(5)の合成〉
無水ジメチルスルホキシド680mg(8,7m mo
l )の無水塩化メチレン15m1溶液にオキザリルジ
クロリド0.38d (4,4m mol >を−70
℃で5分間かけて滴下し、さらに10分間同温度で撹拌
した。これに上記得られたエリトロ体ニドレオ体=64
:36の化合物(4)1.00(1(2,9m mol
)の無水塩化メチレン4dを滴下し9分間−70°C
で撹拌した。これに無水トリエチルアミン2.0威(1
4m mo! )を滴下して徐々に室温に戻した後ヘキ
サンを加え、セライト−545を通して濾過し、濾液を
1規定塩酸で洗浄した。水層を塩化メチレンで3回抽出
し、抽出物を飽和食塩水で洗浄し無水硫酸マグネシウム
で乾燥した。溶媒を減圧留去し、シリカゲルカラムクロ
マトグラフィー(エチルエーテル:ヘキサン=1:10
(容量))で精製し、下記化学式で示される(23.6
3)体のエチニルケトン誘導体(5)ssomgを得た
(収率55%)。(However, Bn represents a benzyl group) <Synthesis of compound (5)> 680 mg of anhydrous dimethyl sulfoxide (8.7 m mo
0.38 d (4.4 mmol) of oxalyl dichloride was added to 15 ml of anhydrous methylene chloride solution of -70
The mixture was added dropwise over 5 minutes at ℃, and further stirred at the same temperature for 10 minutes. In addition to this, the erythro body obtained above and the Nido leo body = 64
:36 compound (4) 1.00(1(2.9m mol
) of anhydrous methylene chloride was added dropwise at -70°C for 9 minutes.
It was stirred with This was added with 2.0 parts of anhydrous triethylamine (1
4m mo! ) was added dropwise and the temperature was gradually returned to room temperature, then hexane was added and the mixture was filtered through Celite-545, and the filtrate was washed with 1N hydrochloric acid. The aqueous layer was extracted three times with methylene chloride, and the extract was washed with saturated brine and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure and subjected to silica gel column chromatography (ethyl ether:hexane = 1:10).
(volume)) and is purified by the following chemical formula (23.6
3) ethynyl ketone derivative (5) ssomg was obtained (yield 55%).
(但し、Bnはベンジル基を表わす)
’HNMR(CDCI13)
δ:0.86 (3H,br t、 J= 7
.2Hz。(However, Bn represents a benzyl group) 'HNMR (CDCI13) δ: 0.86 (3H, br t, J = 7
.. 2Hz.
CH3)
1.0〜1.9 (8H,m、 CH2)1.38
(3H,S、CH3)t、47 (3H,
S、CH3)a、o2 (IH,dd、 J=
5.6Hz。CH3) 1.0-1.9 (8H, m, CH2) 1.38
(3H,S,CH3)t,47 (3H,
S, CH3) a, o2 (IH, dd, J=
5.6Hz.
8.24tlZ、 0H) 4.18 (IH,dd、 J= 6.4Hz。8.24tlZ, 0H) 4.18 (IH, dd, J = 6.4Hz.
8.24H2,CH)
4.42 (11=l、 d、 J=11.5H
7,CH)4.70 (IH,d、 J=11.
5Hz、 CH)4.86 (1H,dd、 J
= 5.6H2゜8.4NZ、 CH)
7.31 (5H,S、 Cs Hs )IR
νmax (neat)
695、 735. 835.1060.1220.1
320゜137C)、 13B0.1450.1675
.2200.2B60゜2920、3020Cm−1
〈化合物(6)の合成〉
上記得られた(23.63>体のエチニルケトン誘導体
(5) 550mg(1,6mmol)の無水エーテ
ル16d中へ一30℃で濃度0.26molの水素化ホ
ウ素亜鉛−エチルエーテル溶液9.6m (2,5m
mol >を窒素雰囲気下5分間かけて滴下し、ざらに
30分間撹拌した。反応終了後、水及び0.5規定塩酸
2(7を加え、0℃で30分子謂撹拌した。水層をエチ
ルエーテルで3回抽出し、抽出液を飽和型費水及び飽和
食塩水で順次洗浄し無水硫酸マグネシウムで乾燥した。8.24H2, CH) 4.42 (11=l, d, J=11.5H
7, CH) 4.70 (IH, d, J=11.
5Hz, CH) 4.86 (1H, dd, J
= 5.6H2゜8.4NZ, CH) 7.31 (5H,S, Cs Hs)IR
νmax (neat) 695, 735. 835.1060.1220.1
320°137C), 13B0.1450.1675
.. 2200.2B60゜2920, 3020Cm-1 <Synthesis of compound (6)> The above-obtained (23.63>-ethynyl ketone derivative (5)) was added to 550 mg (1.6 mmol) of anhydrous ether 16d at -30°C. 9.6 m of zinc borohydride-ethyl ether solution with a concentration of 0.26 mol (2.5 m
mol> was added dropwise over 5 minutes under a nitrogen atmosphere, and the mixture was roughly stirred for 30 minutes. After the reaction was completed, water and 0.5 N hydrochloric acid 2 (7) were added and stirred at 0°C for 30 molecules. The aqueous layer was extracted three times with ethyl ether, and the extract was sequentially extracted with saturated water and saturated brine. It was washed and dried over anhydrous magnesium sulfate.
溶媒を減圧留去し、シリカゲルカラムクロマトグラフィ
ー(エチルエーテル:ヘキサン=1:3 (容量))で
精製して下記化学式で示される(23.5R,63)体
のエチニルアルコール誘導体(6)(エリトロ体ニドレ
オ体=90:10(重量))349mgを得た(収率6
3%)。The solvent was distilled off under reduced pressure and purified by silica gel column chromatography (ethyl ether:hexane = 1:3 (volume)) to obtain the (23.5R, 63) ethynyl alcohol derivative (6) (erythro 349 mg (yield: 6
3%).
(但し、Bnはベンジル基を表わす)
’HNMR(CDCb )
δ:0.87 (3H,br t、 J= 7
.2Hz。(However, Bn represents a benzyl group) 'HNMR (CDCb) δ: 0.87 (3H, br t, J = 7
.. 2Hz.
CH3)
1.0〜1.8 (8H,m、 CH2)1.36
(3H,S、 CI−(3)1.45 (
3H,s、CH3)3.49 (、IH,dt、
J= 3.8H2゜6.4H2,CH)
3.88 (IH,dd、J= 6゜4H2゜7
.7Hz、 CH)
4.12 (IH,dd、 J= 6.4H2゜
7.7Hz、 CH)
4.4〜4.7 (IH,m、 J= 1.5Hz。CH3) 1.0-1.8 (8H, m, CH2) 1.36
(3H,S, CI-(3)1.45 (
3H,s,CH3)3.49 (,IH,dt,
J = 3.8H2゜6.4H2, CH) 3.88 (IH, dd, J = 6゜4H2゜7
.. 7Hz, CH) 4.12 (IH, dd, J= 6.4H2゜7.7Hz, CH) 4.4~4.7 (IH, m, J= 1.5Hz.
3.8H2,Cl−1>
4.59 (2H,S、CH2)4.69
(1H,ddd、 J= 1.5Hz。3.8H2,Cl-1>4.59 (2H,S,CH2)4.69
(1H, ddd, J= 1.5Hz.
8.4H2,6,4H2,CH)
1゜30 (5H,S、C6H5)13CNMR
(CDα3)
δ:13゜98. 22.54. 25.27. 25
.9&、 26.22゜30.06. 31.85.
64.16. 65.57. 69.94゜72.4
9. 81.50. 83.70. 84.00.10
0.31゜127.83.128.40.138.21
〈化合物(B)の合成〉
上記得られた(2S、 5R,63)体のエチニルアル
コール誘導体(6) 105m(] (00,30m
mol>の無水テトラヒドロフラン2d溶液を水素化リ
チウムアルミニウム24.1mg(0,63m mof
)の無水テトラヒドロフラン5rni中に0°Cで加え
、18分間撹拌還流した。反応終了後、酢酸エチル、エ
タノール、水、0.1規定塩酸を順次加えて分解し、水
層をエチルエーテルで2回抽出した。抽出液を飽和食塩
水で洗浄し、無水硫酸マグネシウムで乾燥後、溶媒を減
圧留去し、シリカゲルカラムクロマトグラフィー(エチ
ルエーテル:ヘキサン=1:3(容量))で精製して下
記化学式で示される(23.5R,63)体のアリルア
ルコール誘導体(B ) 8o、 imgを得た(収率
76%)。8.4H2,6,4H2,CH) 1゜30 (5H,S,C6H5)13CNMR
(CDα3) δ: 13°98. 22.54. 25.27. 25
.. 9 &, 26.22°30.06. 31.85.
64.16. 65.57. 69.94°72.4
9. 81.50. 83.70. 84.00.10
0.31゜127.83.128.40.138.21
<Synthesis of compound (B)> Ethynyl alcohol derivative (6) of the (2S, 5R, 63) form obtained above 105m(] (00,30m
mol> of anhydrous tetrahydrofuran to 24.1 mg of lithium aluminum hydride (0.63 m mof
) in 5 rni of anhydrous tetrahydrofuran at 0°C, and the mixture was stirred and refluxed for 18 minutes. After the reaction was completed, ethyl acetate, ethanol, water, and 0.1N hydrochloric acid were sequentially added for decomposition, and the aqueous layer was extracted twice with ethyl ether. The extract was washed with saturated brine, dried over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure, and purified by silica gel column chromatography (ethyl ether:hexane = 1:3 (volume)) to obtain a product represented by the chemical formula below. A (23.5R,63) allyl alcohol derivative (B) 8o, img was obtained (yield 76%).
(但し、Bnはベンジル基を表わす)
’HNMR(CDCf’3)
δ:0.86 (3H,t、 J= 5.4tl
z。(However, Bn represents a benzyl group) 'HNMR (CDCf'3) δ: 0.86 (3H, t, J = 5.4tl
z.
CH3)
1.38 (3H,S、 CH3)1.4
0 (3H,S、CH3)1.04〜1.8
(8H,m、 CH2)3.2〜3.5 (IH,m
、CH)3.52 (IH,dd、 J= 7.
7Hz。CH3) 1.38 (3H,S, CH3) 1.4
0 (3H,S,CH3)1.04~1.8
(8H, m, CH2) 3.2~3.5 (IH, m
, CH) 3.52 (IH, dd, J= 7.
7Hz.
7.7H2,CH)
4.08 (IH,dd、 J= 6.4H2゜
8、OH7,CH)
r3CNMR(CD(ff13)
δ: 14.02. 22.61. 25.46.
25.92. 26.72゜29.42. 31.93
. 69.44. 72.22. 72.56゜82.
18.127.72.127.79.128.40.1
29.89゜132.47.140.60
く化合物(A>の合成〉
上記得られた(2S、 5R,63)体のアリルアルコ
ール誘導体(B ) 80.1mg(0,23m mo
l ) 、トリエチルオルトアセテート0.15m1(
0,82m mol >及び触ts量のヘプタノイック
アシッドをキシレン3d中160’Cで20分間加熱反
応させ、キシレンと生成したエタノールを減圧留去し、
反応終了後飽和重曹水で分解した。水層をエチルエーテ
ルで2回抽出し、抽出物を飽和食塩水で洗浄した後無水
硫酸マグネシウムで乾燥した。溶媒を減圧留去後、シリ
カゲルカラムクロマトグラフィー(エチルエ−チル:ヘ
キサン=1’:10(容M))で精製して下記化学式で
示される( 1′S、 33.63)体のT−不飽和カ
ルボン酸エチル(A> 65.6mgを得た(収率68
%)。7.7H2, CH) 4.08 (IH, dd, J = 6.4H2゜8, OH7, CH) r3CNMR (CD (ff13) δ: 14.02. 22.61. 25.46.
25.92. 26.72°29.42. 31.93
.. 69.44. 72.22. 72.56°82.
18.127.72.127.79.128.40.1
29.89゜132.47.140.60 Synthesis of compound (A>) 80.1 mg (0,23 m mo
l ), triethyl orthoacetate 0.15 ml (
Heptanoic acid in an amount of 0.82 mmol> and a ts amount was heated and reacted in xylene 3d at 160'C for 20 minutes, and the xylene and the generated ethanol were distilled off under reduced pressure.
After the reaction was completed, it was decomposed with saturated aqueous sodium bicarbonate solution. The aqueous layer was extracted twice with ethyl ether, and the extract was washed with saturated brine and dried over anhydrous magnesium sulfate. After evaporating the solvent under reduced pressure, it was purified by silica gel column chromatography (ethyl ethyl:hexane = 1':10 (volume M)) to obtain the (1'S, 33.63) form of T-union represented by the chemical formula below. Obtained 65.6 mg of saturated ethyl carboxylate (A>68
%).
○
(A>
(但し、3nはベンジル基を表わす)
’HNMR(CDCb )
δ:0.8B (3H,br t、 J= 7
.2H2゜CH3)
t、o 〜ta (8H,m、 CH2)1.
33 (3H,S、CH3)1.41 (
3H,S、CH3)2.40 (it(、dd、
J= 9.0l−IZ。○ (A> (3n represents a benzyl group) 'HNMR (CDCb) δ: 0.8B (3H, br t, J= 7
.. 2H2°CH3) t, o ~ta (8H, m, CH2)1.
33 (3H,S,CH3)1.41 (
3H,S,CH3)2.40 (it(,dd,
J=9.0l-IZ.
14.7H2,CH)
2.50 < IH,dd、 J= 5.1Hz
。14.7H2, CH) 2.50 < IH, dd, J= 5.1Hz
.
14.7H2,CH)
2.6〜3.0 (IH,m、CH)3.5〜3.8
(2H,m、 CH2)3.9〜4.3 (2H
,m、CHx2 >4.09 (2H,Q、 J
= 7.21′lZ。14.7H2, CH) 2.6-3.0 (IH, m, CH) 3.5-3.8
(2H, m, CH2) 3.9~4.3 (2H
, m, CHx2 >4.09 (2H,Q, J
= 7.21′lZ.
CH20) 4.31 (IH,d、 J=11.7Hz。CH20) 4.31 (IH, d, J = 11.7Hz.
CH2Cs Hs ) 4.55 (IH,d、 J=11.711Z。CH2Cs Hs) 4.55 (IH, d, J = 11.711Z.
CH2C8Hs )
5.2〜5.7 (2H,m、 =CH−)7.27
(5H,S、C6H5)13ONMR(CDC
13)
δ: 14.00. 14.25. 22.59. 2
5.03. 26.30゜31.77、 35.72.
36.50. 41.77、 60.32゜6B、8
1. 69.79. 77.30. 79.74.10
9.08゜127.28.121.72.128.20
.130.84.134.45゜139.00.171
.79
上記得られた本発明の目的化合物であるT−不飽和カル
ボン酸誘導体を用いて、以下の例に従つてプロスタグラ
ンジン合成のための鍵中間体である前記一般式(P)で
表わされる光学活性γ−ラクトン誘導体を合成した。CH2C8Hs) 5.2-5.7 (2H, m, =CH-)7.27
(5H,S,C6H5)13ONMR(CDC
13) δ: 14.00. 14.25. 22.59. 2
5.03. 26.30°31.77, 35.72.
36.50. 41.77, 60.32゜6B, 8
1. 69.79. 77.30. 79.74.10
9.08°127.28.121.72.128.20
.. 130.84.134.45゜139.00.171
.. 79 Using the T-unsaturated carboxylic acid derivative obtained above, which is the target compound of the present invention, according to the following example, the compound represented by the general formula (P), which is a key intermediate for prostaglandin synthesis, is synthesized. An optically active γ-lactone derivative was synthesized.
〈化合物(P)の合成〉
上記得られた( 1′S、 33.63>体のT−不飽
和カルボン酸エチル(A ) 65mq (0,16m
mol ) 、メタノール5ml、水1.25m及び
Cu5Oa ・5H207861g (0,751n
moi)を13時間撹拌遠流した。反応終了後、エチル
エーテルを加えてセライト−545により濾過し、濾液
を飽和食塩水で洗浄した後無水硫酸マグネシウムで乾燥
した。溶媒を減圧留去後、シリカゲルカラムクロマトグ
ラフィー(酢酸エチル:ヘキサン=1:5(容量))で
精製して下記化学式で示される(33. 3“S、 4
S)体のγ−ラクトン誘導体(P ) 35.5mgを
得た(収率69%)。<Synthesis of compound (P)> 65 mq (0,16 m
mol), methanol 5ml, water 1.25m and Cu5Oa ・5H207861g (0,751n
moi) was stirred and centrifuged for 13 hours. After the reaction was completed, ethyl ether was added and the mixture was filtered through Celite-545. The filtrate was washed with saturated brine and dried over anhydrous magnesium sulfate. After evaporating the solvent under reduced pressure, it was purified by silica gel column chromatography (ethyl acetate:hexane = 1:5 (volume)) to obtain a product represented by the following chemical formula (33.3"S, 4
35.5 mg of a γ-lactone derivative (P) in the S) form was obtained (yield 69%).
8n
(但し、Bnはベンジル基を表わす)
’HNMR(CDC13”)
δ :0.86 (3H,br t、
J= 7.2Hz。8n (However, Bn represents a benzyl group) 'HNMR (CDC13'') δ: 0.86 (3H, br t,
J = 7.2Hz.
CH3)
1.0〜1.8 (8H,m、 CH2)3.72〜
3.9 (5H,m、 CI−(2、CH)4.4〜
4.’7 (、IH,m、CH)4.36 (I
H,d、 J=11.7Hz。CH3) 1.0~1.8 (8H, m, CH2) 3.72~
3.9 (5H, m, CI-(2, CH) 4.4~
4. '7 (,IH,m,CH)4.36 (I
H, d, J = 11.7Hz.
CH2)
4.51 (IH,d、 J=11.7H2゜C
H2)
5.55 (IH,dd、 J=
、、6.7Hz。CH2) 4.51 (IH, d, J=11.7H2゜C
H2) 5.55 (IH, dd, J=
,,6.7Hz.
15.4H2,=CH) 5.68 (IH,dd、J= 7.7t(z。15.4H2,=CH) 5.68 (IH, dd, J = 7.7t (z.
15.4H7,=CH)
7.29 (5H,S、 CB H5)13CN
MR(CDCU3)
δ: 14.00. 22.57. 24.98.
31.69. 34.94゜41.02. 62.27
. 70.42. 79.50. 82.60゜127
.52.127.62.128.23.135.62.
138゜63゜176.48
(発明の効果)
本発明の光学活性化合物は、プロスタグランジンを合成
する際の鍵中間体となる光学活性γ−ラクトン誘導体製
造のための原料として重要な化合物であり、この化合物
を用いることにより比較的簡便に、効率よく鍵中間体が
製造できる。15.4H7,=CH) 7.29 (5H,S, CB H5)13CN
MR (CDCU3) δ: 14.00. 22.57. 24.98.
31.69. 34.94°41.02. 62.27
.. 70.42. 79.50. 82.60°127
.. 52.127.62.128.23.135.62.
138゜63゜176.48 (Effects of the Invention) The optically active compound of the present invention is an important compound as a raw material for the production of optically active γ-lactone derivatives, which are key intermediates in prostaglandin synthesis. By using this compound, the key intermediate can be produced relatively easily and efficiently.
Claims (1)
していてもよいアルキル基、シクロアルキル基及び芳香
環もしくはアルキル基にヘテロ原子を有するアラルキル
基から選ばれた炭素数1〜12の基、R^2は水素原子
又はアシル基、シリル基、アラルキル基及びアルキルオ
キシアルキル基から選ばれた容易に脱離可能な保護基、
R^4は炭素数1〜5の低級アルキル基を表わし、*の
符号は不斉炭素原子を表わす。 (2)一般式(A)のR^1が炭素数4〜10のアルキ
ル基である請求項1記載の光学活性化合物。 (3)アルキル基がペンチル基である請求項2記載の光
学活性化合物。 (4)一般式(A)のR^2がアラルキル基である請求
項1〜3いずれかに記載の光学活性化合物。 (5)アラルキル基がベンジル基である請求項4記載の
光学活性化合物。 (6)一般式(A)の化合物が光学活性(1′S、3S
、6S)体である請求項1〜5いずれかに記載の化合物
。 (7)下記一般式(A) ▲数式、化学式、表等があります▼(A) (上記一般式(A)において、R^1はアルコキシ基を
有していてもよいアルキル基、シクロアルキル基及び芳
香環もしくはアルキル基にヘテロ原子を有するアラルキ
ル基から選ばれた炭素数1〜12の基、R^2は水素原
子又はアシル基、シリル基、アラルキル基及びアルキル
オキシアルキル基から選ばれた容易に脱離可能な保護基
、R^4は炭素数1〜5の低級アルキル基を表わし、*
の符号は不斉炭素原子を表わす) で表わされる光学活性化合物を製造するにあたり、下記
一般式(B) ▲数式、化学式、表等があります▼(B) (上記一般式(B)において、R^1、R^2及び*の
符号は一般式(A)のR^1、R^2及び*の符号と同
じ意味を表わす) で表わされる光学活性化合物を、下記一般式(D)CH
_3C(OR^4)_3(D) (上記一般式(D)において、R^4は炭素数1〜5の
低級アルキル基を表わす) で表わされるオルト酢酸トリアルキルと酸触媒の存在下
で加熱反応させることを特徴とする光学活性化合物の製
法。 (8)一般式(A)のR^1が炭素数4〜10のアルキ
ル基である請求項7記載の製法。(9)アルキル基がペ
ンチル基である請求項8記載の製法。 (10)一般式(A)のR^2がアラルキル基である請
求項7〜9いずれかに記載の製法。 (11)アラルキル基がベンジル基である請求項10記
載の製法。 (12)一般式(A)の化合物が光学活性(1′S、3
S、6S)体である請求項7〜11いずれかに記載の製
法。[Scope of Claims] (1) An optically active compound represented by the following general formula (A). ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (A) In the above general formula (A), R^1 is an alkyl group that may have an alkoxy group, a cycloalkyl group, an aromatic ring, or a hetero atom in the alkyl group. a group having 1 to 12 carbon atoms selected from aralkyl groups, R^2 is a hydrogen atom or an easily removable protecting group selected from acyl groups, silyl groups, aralkyl groups, and alkyloxyalkyl groups;
R^4 represents a lower alkyl group having 1 to 5 carbon atoms, and the symbol * represents an asymmetric carbon atom. (2) The optically active compound according to claim 1, wherein R^1 in general formula (A) is an alkyl group having 4 to 10 carbon atoms. (3) The optically active compound according to claim 2, wherein the alkyl group is a pentyl group. (4) The optically active compound according to any one of claims 1 to 3, wherein R^2 in general formula (A) is an aralkyl group. (5) The optically active compound according to claim 4, wherein the aralkyl group is a benzyl group. (6) The compound of general formula (A) has optical activity (1'S, 3S
, 6S) compound according to any one of claims 1 to 5. (7) The following general formula (A) ▲ Numerical formulas, chemical formulas, tables, etc. are included ▼ (A) (In the above general formula (A), R^1 is an alkyl group that may have an alkoxy group, a cycloalkyl group and a group having 1 to 12 carbon atoms selected from aralkyl groups having a heteroatom in an aromatic ring or an alkyl group, R^2 is a hydrogen atom or a group selected from an acyl group, a silyl group, an aralkyl group, and an alkyloxyalkyl group. R^4 represents a lower alkyl group having 1 to 5 carbon atoms, *
The symbol represents an asymmetric carbon atom) In order to produce an optically active compound represented by the following general formula (B) ▲ Numerical formulas, chemical formulas, tables, etc. ▼ (B) (In the above general formula (B), R The symbols ^1, R^2, and * have the same meanings as the symbols R^1, R^2, and * in general formula (A).) The optically active compound represented by the following general formula (D) CH
Heating in the presence of trialkyl orthoacetate represented by _3C(OR^4)_3(D) (in the above general formula (D), R^4 represents a lower alkyl group having 1 to 5 carbon atoms) and an acid catalyst. A method for producing an optically active compound, which is characterized by a reaction. (8) The method according to claim 7, wherein R^1 in general formula (A) is an alkyl group having 4 to 10 carbon atoms. (9) The method according to claim 8, wherein the alkyl group is a pentyl group. (10) The method according to any one of claims 7 to 9, wherein R^2 in general formula (A) is an aralkyl group. (11) The method according to claim 10, wherein the aralkyl group is a benzyl group. (12) The compound of general formula (A) has optical activity (1'S, 3
The manufacturing method according to any one of claims 7 to 11, which is S, 6S) form.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1140798A JPH0651694B2 (en) | 1989-06-01 | 1989-06-01 | Optically active compound |
JP5293228A JP2743798B2 (en) | 1989-06-01 | 1993-11-24 | Preparation of optically active compounds |
JP5293225A JP2785657B2 (en) | 1989-06-01 | 1993-11-24 | Preparation of optically active compounds |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1140798A JPH0651694B2 (en) | 1989-06-01 | 1989-06-01 | Optically active compound |
JP5293228A JP2743798B2 (en) | 1989-06-01 | 1993-11-24 | Preparation of optically active compounds |
JP5293225A JP2785657B2 (en) | 1989-06-01 | 1993-11-24 | Preparation of optically active compounds |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5293228A Division JP2743798B2 (en) | 1989-06-01 | 1993-11-24 | Preparation of optically active compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH035475A true JPH035475A (en) | 1991-01-11 |
JPH0651694B2 JPH0651694B2 (en) | 1994-07-06 |
Family
ID=27318128
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1140798A Expired - Fee Related JPH0651694B2 (en) | 1989-06-01 | 1989-06-01 | Optically active compound |
JP5293225A Expired - Lifetime JP2785657B2 (en) | 1989-06-01 | 1993-11-24 | Preparation of optically active compounds |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5293225A Expired - Lifetime JP2785657B2 (en) | 1989-06-01 | 1993-11-24 | Preparation of optically active compounds |
Country Status (1)
Country | Link |
---|---|
JP (2) | JPH0651694B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6293886B1 (en) * | 1998-10-16 | 2001-09-25 | Bando Chemical Industries Ltd. | Heavy-duty power transmission V-belt |
-
1989
- 1989-06-01 JP JP1140798A patent/JPH0651694B2/en not_active Expired - Fee Related
-
1993
- 1993-11-24 JP JP5293225A patent/JP2785657B2/en not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6293886B1 (en) * | 1998-10-16 | 2001-09-25 | Bando Chemical Industries Ltd. | Heavy-duty power transmission V-belt |
Also Published As
Publication number | Publication date |
---|---|
JPH0651694B2 (en) | 1994-07-06 |
JP2785657B2 (en) | 1998-08-13 |
JPH06228124A (en) | 1994-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bartlett et al. | Construction of trans-fused polycyclic ethers: methodology for the brevetoxins | |
Srinivas et al. | Stereoselective total synthesis of (+)-varitriol | |
JPH05331128A (en) | @(3754/24)r)-@(3754/24)-)-4-cyano-3-hydroxylactic acid t-butyl ester and its production | |
JPH035475A (en) | Optically active compound and its production | |
EP0585104B1 (en) | A method of preparing a saturated monocyclic hydrocarbon compound and an intermediate therefor | |
EP0362816B1 (en) | Cyclopenteneheptanoic acid derivatives and method of preparation thereof | |
US4958037A (en) | Precursors and synthesis of methyl-9-oxo-11α, 16-dihydroxy-16-vinyl-5-cis-13-trans-prostadienoates | |
JPH035470A (en) | Production of optically active gamma-lactone derivative | |
JP2743797B2 (en) | Preparation of optically active compounds | |
JP2743798B2 (en) | Preparation of optically active compounds | |
JPH035472A (en) | Optically active compound and its production | |
JPH035474A (en) | Optically active compound and its production | |
US4137244A (en) | Asymmetric synthesis of optically active prostaglandins | |
JP2785658B2 (en) | Preparation of optically active compounds | |
EP0213313A2 (en) | Precursors and synthesis of methyl-9-oxo-11 alpha, 16-dihydroxy-16-vinyl-5-cis-13-trans prostadienoates | |
JP2654835B2 (en) | Optically active 4-en-6-ol compounds, intermediates for their production and methods for their production | |
JP2011523631A (en) | Method for obtaining synatoline C3 and C1 | |
JPS5921864B2 (en) | Fluoroprostaglandins and their production method | |
JP3692553B2 (en) | Method for producing difluorolactones | |
JPS5944336A (en) | Novel preparation of 2-allylcyclopentanones | |
US4496759A (en) | Novel prostaglandin analogues and process for making same | |
JPS6236012B2 (en) | ||
JPS60222436A (en) | Intermediate for manufacturing prostaglandins | |
JPH03255051A (en) | 11-epiisocarbacyclins and its preparation | |
JPH0351694B2 (en) |